An, R., Wang, Y., Voeller, D., Gower, A., Kim, I., Zhang, Y., & Giaccone, G. (2016). CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma. Oncotarget.

An, Rong, Yisong Wang, Donna Voeller, Arjan Gower, In-Kyu Kim, Yu-Wen Zhang, و Giuseppe Giaccone. "CRKL Mediates EML4-ALK Signaling and Is a Potential Therapeutic Target for ALK-rearranged Lung Adenocarcinoma." Oncotarget 2016.

An, Rong, et al. "CRKL Mediates EML4-ALK Signaling and Is a Potential Therapeutic Target for ALK-rearranged Lung Adenocarcinoma." Oncotarget 2016.